We have identified a Coffin-Lowry syndrome pedigree where the disorder is a
ssociated with a novel splice site mutation in the RSK2 gene, leading to in
-phase skipping of exon 5, Western blot analysis, using an antibody directe
d against the C-terminus of RSK2, failed to reveal RSK2 in this patient, su
ggesting strongly that the resulting internally deleted protein is unstable
, The mutation was present in the DNA of one affected son and one manifesti
ng daughter but was absent in two asymptomatic daughters, who carry the at-
risk haplotype, and in the mother's somatic cell (lymphocyte) DNA. The resu
lts are consistent with the mutation arising as a postzygotic event in the
mother, who therefore is a germinal mosaic. The application of linked marke
rs to identify the disease allele for conventional genetic counselling woul
d have been misleading in this family. This observation again highlights th
e importance of precise identification of the disease-causing mutation.